These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6753735)

  • 1. [Aclacinomycin A: a new antitumor antibiotic].
    Egorov LV; Ivanitskaia LP; Navashin SM
    Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
    [No Abstract]   [Full Text] [Related]  

  • 2. New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1981; 76():21-40. PubMed ID: 6940212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
    Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antibiotic galtamycin. Its fermentation, isolation, physicochemical and biological properties].
    Korobkova TP; Singal EM; Ivanitskaia LP; Kudinova MK; Karbyshev VD
    Antibiot Med Biotekhnol; 1986 Jun; 31(6):428-31. PubMed ID: 3461745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties.
    Oki T; Kitamura I; Yoshimoto A; Matsuzawa Y; Shibamoto N; Ogasawara T; Inui T; Takamatsu A; Takeuchi T; Masuda T; Hamada M; Suda H; Ishizuka M; Sawa T; Umezawa H
    J Antibiot (Tokyo); 1979 Aug; 32(8):791-800. PubMed ID: 500500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antitumor antibiotics: 13-methylaclacinomycin A and its derivatives.
    Soga K; Furusho H; Mori S; Oki T
    J Antibiot (Tokyo); 1981 Jun; 34(6):770-3. PubMed ID: 6944303
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S; Fuks JZ; Wiernik PH
    J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a new anthracycline antibiotic, aclacinomycin-A, in patients with advanced malignant lymphoma.
    Warrell RP; Kempin SJ
    Am J Clin Oncol; 1983 Feb; 6(1):81-4. PubMed ID: 6573124
    [No Abstract]   [Full Text] [Related]  

  • 10. Aclacinomycin A.
    Oka S; Mathé G; Mitrou PS
    Cancer Treat Rev; 1984 Dec; 11(4):299-302. PubMed ID: 6598408
    [No Abstract]   [Full Text] [Related]  

  • 11. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
    Warrell RP
    Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
    Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New antitumor antibiotics 5590 and 2928].
    Gauze GF; Maksimova TS; Ol'khovatova OL; Laĭko AV; Selezneva TI
    Antibiotiki; 1981 Jul; 26(7):483-8. PubMed ID: 6895012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New anthracycline antibiotics taurimycins A and B produced by a Str. tauricus No. 7036-1 culture].
    Frolova VI; Kuzovkov AD; Rozynov BV; Taĭg MM; Ivanitskaia LP
    Antibiotiki; 1982 May; 27(5):326-31. PubMed ID: 6954874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
    Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
    J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133.
    Kim HS; Kim YH; Yoo OJ; Lee JJ
    Biosci Biotechnol Biochem; 1996 May; 60(5):906-8. PubMed ID: 8704322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experiences with aclacinomycin-A.
    Furue H; Komita T; Nakao I; Furukawa I; Kanko T; Yokoyama T
    Recent Results Cancer Res; 1978; 63():241-6. PubMed ID: 360331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of clinical studies on aclacinomycin A--phase I and preliminary phase II evaluation of ACM.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):37-49. PubMed ID: 572582
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary clinical study of aclacinomycin A.
    Majima H
    Recent Results Cancer Res; 1980; 70():75-81. PubMed ID: 6986643
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physicochemical properties and biological activity of an antitumor substance isolated from Bacillus mesentericus culture broth].
    Zatula DG; Tanasienko OA; Khomiak OG; Sytenko VK; Siadro TA
    Mikrobiol Zh (1978); 1980; 42(6):766-8. PubMed ID: 7464577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.